In re Johnson & Johnson Derivative Litigation

Court: United States District Court of New Jersey
Case Number: 10-2033 (FLW)
Judge: Freda L. Wolfson
Case Contacts: Mark Lebovitch, Jeroen van Kwawegen

This is a shareholder derivative action brought by Lead Plaintiff Minneapolis Firefighters' Relief Association and other shareholders of Johnson & Johnson ("J&J" or the "Company"), against J&J's senior management and board of directors (the "Board").

Plaintiffs allege that J&J's senior management and the Board breached their fiduciary duties by permitting and fostering a culture of systemic and widespread legal violations in J&J's manufacturing and marketing of numerous drugs and medical devices. On August 17, 2010, the Court consolidated the pending J&J federal derivative actions and appointed BLBG as Co-Lead Counsel.
On December 17, 2010, BLBG filed an amended, consolidated and verified complaint (the "Amended Complaint") alleging, among other things, that J&J's senior management and Board deliberately ignored an avalanche of red flags about persistent legal and compliance violations concerning the Company's drug and medical device manufacturing processes and its drug marketing practices. The Complaint alleges that the recent, historic recalls of high profile brands like Tylenol, Motrin, Rolaids and Benadryl are but the tip of the iceberg, and that J&J's unlawful drug manufacturing practices date back to at least 2005, when the FDA required the Company to recall numerous drugs. Similarly, the Complaint alleges that J&J's unlawful promotion of key drugs started years ago and put the Company at risk of significant fines and potential exclusion from federal health care programs like Medicare and Medicaid.  

The Complaint seeks to hold Defendants accountable for the resulting damage to the Company and to ensure that J&J implements meaningful change to avoid similar legal and compliance violations in the future. Click here to view the Amended Complaint.

Other Cases of Interest

  • BGC Partners, Inc.
    Delaware Court of Chancery Jeroen van Kwawegen, Andrew Blumberg, Christopher J. Orrico
  • Qualcomm, Inc.
    Delaware Court of Chancery Mark Lebovitch
  • Longs Drug Stores Corporation Shareholder Litigation
    Superior Court for the State of California, County of Contra Costa Mark Lebovitch
  • Synchrony Financial
    District of Connecticut Jeroen van Kwawegen, Adam H. Wierzbowski, Kate Aufses
  • DXC Technology Company
    Eastern District of Virginia John C. Browne, Jeroen van Kwawegen, Lauren McMillen Ormsbee, Jesse L. Jensen, Kyle Panton
  • Qualcomm, Inc.
    Southern District of California Salvatore J. Graziano, Jeroen van Kwawegen, Jonathan D. Uslaner, Richard D. Gluck, Rebecca E. Boon, Kyle Panton, Lauren M. Cruz
  • SCANA Corporation
    District of South Carolina (Columbia Division) John C. Browne, Jeroen van Kwawegen, Lauren McMillen Ormsbee, , Michael Mathai, Kate Aufses
  • Oracle Corporation
    Northern District of California John Rizio-Hamilton, Mark Lebovitch, Jonathan D. Uslaner, Abe Alexander, Julia Tebor
  • NVIDIA Corporation
    Northern District of California John C. Browne, Jeroen van Kwawegen, Jonathan D. Uslaner, Michael Mathai, Lauren M. Cruz